This is a significant omission, as cognitive impairment has been shown to largely affect functional recovery in these patients, and comprehensive considerations on the potential ability of 5‐HT1A (partial) agonists to alleviate cognitive deficits are lacking. This evidence concerns the gene HTR1A and Cognitive impairment.